GSK-3 inhibitor TDZD-8 reduces neonatal hypoxic-ischemic brain injury in mice

Huang, S; Wang, HT; Turlova, E; Abussaud, A; Ji, X; Britto, LR; Miller, SP; Martinez, A; Sun, HS; Feng, ZP

Sun, HS; Feng, ZP (reprint author), Univ Toronto, Toronto, ON, Canada.

CNS NEUROSCIENCE & THERAPEUTICS, 2017; 23 (5): 405

Abstract

AimsGlycogen synthase kinase 3 (GSK-3) is activated following hypoxic-ischemic (HI) brain injury. TDZD-8 is a specific GSK-3 inhibitor. Currently, the......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索